“A preliminary study on the prognostic significance of cysteine-rich EGF ligand domain 2 protein (CRELD2) in patients with triple negative breast cancer” (2025) Biomolecules and Biomedicine, pp. 1663–1671. doi:10.17305/bb.2024.11865.